$1.21
-0.03-2.42%
At close: May 8, 5:00 PM EST
$1.23
0.01971.63%
After Hours: May 8, 7:49 PM EST
Heron Therapeutics Inc Earnings Estimates
HRTXNASDAQ
Earnings: Q1 2026 earnings announcement before the market open today
Heron Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:HRTX
Heron Therapeutics (HRTX) is scheduled to report Q2 earnings on August 7, 2026. Analysts estimate EPS of $-0.01 and quarterly revenue of $42.78M.
Over the last 4 quarters, Heron Therapeutics has averaged an EPS surprise of 1.08% and a revenue surprise of 0.03%.
Earnings Date
Aug 7
EPS Estimate
$-0.010
Quarterly Revenue Estimate
$42.78M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$154.90M
Heron Therapeutics Earnings History
Analyze the earnings history of Heron Therapeutics using advanced sorting and filters.
Loading calendar...
Heron Therapeutics (HRTX) Earnings Per Share
The chart below shows Heron Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Heron Therapeutics (HRTX) Revenue
The chart below shows Heron Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Heron Therapeutics (NASDAQ:HRTX) reporting earnings?
Heron Therapeutics (HRTX) is scheduled to report earnings on August 7, 2026. The last reported earnings were for reported on May 11, 2026 for Q1.
What were the latest earnings per share (EPS) for Heron Therapeutics (NASDAQ:HRTX)?
The Actual EPS was $0.00, which beat the estimate of $-0.02.
What were Heron Therapeutics’s (NASDAQ:HRTX) revenues?
The Actual Revenue was $0.00, which missed the estimate of $36.60M.
